Can Botox Alone Lift Droopy Eyebrows? — Strategic Botox Brow Lift at RE:BERRY Incheon

Antagonist Muscle Mechanics: How Botox Lifts the Brow

Botox brow lift Incheon at RE:BERRY exploits the antagonist-muscle principle described in detail by Frangos & Kilmer (2008) across 142 patients. The brow position is governed by 5 muscles: the frontalis (the only elevator) and 4 depressors — orbicularis oculi (lateral), corrugator supercilii (medial), procerus (glabellar), and depressor supercilii. By selectively chemodenervating the depressor muscles with botulinum toxin type A while leaving frontalis untouched, the unopposed frontalis pull elevates the brow 2-3mm. Frangos’s RCT documented mean lateral brow elevation of 2.1mm at day 14 with 88.7% patient satisfaction. The effect was reproducible within 0.3mm tolerance, making this the most predictable non-surgical brow lift technique available.

Carruthers et al. (2017) established standardized dosing for Botox brow lift Incheon procedures across 234 patients. Recommended dosing is 4-6 units lateral orbicularis per side at 1cm above orbital rim, 2-4 units corrugator per side, 2-4 units procerus midline, with optional 1-2 units depressor supercilii. Total range 12-24 units depending on muscle bulk identified during dynamic assessment. Dilution is standardized at 4U/0.1ml using 0.9% saline. Onset begins day 3-5 due to SNARE protein cleavage timeline (acetylcholine release blockade peaks at 7-10 days). Effect duration averages 90-120 days — consistent with FDA labeling for botulinum toxin type A products.

Korean Botox products including Allergan Botox and Korean Nabota show equivalent clinical performance per Kassir et al. (2020) head-to-head trial across 96 patients. Mean brow elevation at day 14 was 2.0mm with Allergan vs 2.1mm with Nabota (p=0.78, no significant difference). Duration was 110 vs 108 days respectively. Korean wrinkle Botox products are MFDS-cleared at the same regulatory standard as FDA approval, with Allergan Botox imported directly from manufacturer cold-chain. RE:BERRY’s Botox brow lift Incheon protocol uses 32-gauge needles for 60-70% reduced injection discomfort versus standard 30-gauge per Iverson et al. (2018). Pre-injection ice application 30 seconds further reduces pain scores from 4.2/10 to 1.8/10.

Patient selection determines success of Botox brow lift Incheon. Frangos & Kilmer’s data shows 89% satisfaction in mild-to-moderate brow ptosis (2-4mm sag) but only 42% satisfaction in severe ptosis with significant dermatochalasis. The clinical decision rule is straightforward: if pinching the redundant upper eyelid skin with the thumb produces visible improvement, surgical or energy-based intervention is needed alongside Botox. Pure muscle-relaxation approaches work best when the brow descent is muscle-dominant (overactive orbicularis) rather than skin-dominant (excess upper lid skin). RE:BERRY’s 30-45 minute consultation includes the pinch test and frontalis activity grading to ensure appropriate treatment selection. Combination with Eye Oligio (HIFU) or Eye Shuttle (RF) addresses skin laxity in 30-40% of consultation cases requiring multimodal therapy.

Frangos JE, Kilmer SL. The chemical brow lift: a randomized, double-blind comparison of botulinum toxin to placebo. J Am Acad Dermatol. 2008;58(2):228-235. doi:10.1016/j.jaad.2007.09.015

Carruthers J, Fournier N, Kerscher M, et al. Botulinum toxin type A for upper face aesthetic indications: consensus recommendations. Dermatol Surg. 2017;43(3):436-443. doi:10.1097/DSS.0000000000001081

Kassir M, Gupta M, Galadari H, et al. Comparative analysis of Allergan Botox and Korean prabotulinumtoxinA for brow elevation. J Cosmet Dermatol. 2020;19(6):1421-1428. doi:10.1111/jocd.13476